Literature DB >> 28878856

68Gallium-Arginine-Glycine-Aspartic Acid and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull.

Akintunde Orunmuyi1, Moshe Modiselle1, Thabo Lengana1, Thomas Ebenhan1, Mariza Vorster1, Mike Sathekge1.   

Abstract

We report the case of a 32 year-old male with Chondroblastic Osteosarcoma of the skull, which was imaged with both 18[F]fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and 68Gallium-arginine-glycine-aspartic acid (68Ga-RGD) PET/CT. The 18F-FDG PET/CT did not demonstrate the tumour, whereas the 68Ga-RGD PET/CT clearly depicted a left-sided frontal tumour. 68Ga-RGD PET/CT may be a clinically useful imaging modality for early detection of recurrent osteosarcoma, considering the limitations of 18F-FDG PET in a setting of low glycolytic activity.

Entities:  

Keywords:  18F-FDG; 68Ga-RGD; Chondroblastic Osteosarcoma; PET/CT

Year:  2016        PMID： 28878856      PMCID： PMC5567611          DOI： 10.1007/s13139-016-0400-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  8 in total

1.  Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.

Authors:  Hyung Jun Im; Tae Sung Kim; Seog-Yun Park; Hye Sook Min; June Hyuk Kim; Hyun Guy Kang; Seung Eun Park; Mi Mi Kwon; Jong Hyung Yoon; Hyeon Jin Park; Seok-ki Kim; Byung-Kiu Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-28       Impact factor: 9.236

2.  Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.

Authors:  M W Pedersen; S Holm; E L Lund; L Højgaard; P E Kristjansen
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

Review 3.  RGD-based PET tracers for imaging receptor integrin αv β3 expression.

Authors:  Hancheng Cai; Peter S Conti
Journal:  J Labelled Comp Radiopharm       Date:  2013-02-16       Impact factor: 1.921

4.  PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity.

Authors:  Jin-Young Paik; Bong-Ho Ko; Yearn Seong Choe; Yong Choi; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Biol       Date:  2005-08       Impact factor: 2.408

5.  (68)Ga-Labeling of RGD peptides and biodistribution.

Authors:  Elisabeth Blom; Irina Velikyan; Sergio Estrada; Håkan Hall; Taj Muhammad; Chenmin Ding; Manoj Nair; Bengt Långström
Journal:  Int J Clin Exp Med       Date:  2012-04-06

6.  The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma.

Authors:  Natale Quartuccio; Giorgio Treglia; Marco Salsano; Maria Vittoria Mattoli; Barbara Muoio; Arnoldo Piccardo; Egesta Lopci; Angelina Cistaro
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

7.  PET Imaging of Integrin αVβ3 Expression.

Authors:  Ambros J Beer; Horst Kessler; Hans-Jürgen Wester; Markus Schwaiger
Journal:  Theranostics       Date:  2011-01-17       Impact factor: 11.556

8.  Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.

Authors:  Weiwei Cheng; Zhenyu Wu; Sheng Liang; Hongliang Fu; Shuqi Wu; Yiyun Tang; Zhiyi Ye; Hui Wang
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240
  8 in total
  2 in total

1.  Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans.

Authors:  Thomas Ebenhan; Isabel Schoeman; Daniel D Rossouw; Anne Grobler; Biljana Marjanovic-Painter; Judith Wagener; Hendrik G Kruger; Mike M Sathekge; Jan Rijn Zeevaart
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

Review 2.  Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.

Authors:  Li Li; Xiaoyuan Chen; Jinming Yu; Shuanghu Yuan
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.